Global Biobanking Market

The global biobanking market in 2020 is estimated to be USD ~68 billion, and it is expected to expand at a compound annual growth rate (CAGR) of ~7% from 2022 to 2030. Medicine and cancer genome research are driving the development of this field. In addition, the emergence of COVID-19 puts the biobank at the forefront of epidemic control measures, leading to organic growth in market revenue. The increasing popularity of precision/personalized medicine and genetic testing have become key market drivers. Biobanks play an important role in biomedical research. In the past few decades, some progress has been made in the platforms and tools used in genetic research. This has led to an increase in the demand for biological samples in clinical laboratories to develop genetic testing analyses.

The cooperation between public and private institutions in the biobank has played a vital role in the development of the market. Digitalization, precision medicine, and virtualization are rapidly changing the biobank industry through the development of new methods and collaborative concepts initiated by public and private organizations. Companies in various fields have cooperated with Biobank to accelerate market revenue.

For example, Illumina collaborates with four institutions (University of Colorado Denver, Vanderbilt University, University of Montreal Heart Institute, and Partners HealthCare) to genotype its biological samples for research and development activities. In addition, despite the supply chain obstacles caused by the global pandemic, the market has seen lucrative growth in 2020. This is because biobanks have become a key focus of public health agencies and healthcare providers working to contain the COVID-19 pandemic.

In terms of the number of global cases, the biological sample bank is very important to curb the spread of the virus. High-quality COVID-19 samples are necessary and useful for research and diagnostic purposes, and the biobank is considered an important repository for these samples. Therefore, the biobank is supporting the clinical research and drug discovery process in response to this global disaster.

PRODUCT INSIGHTS:

The biological sample library equipment segment dominates the biological sample library market, with revenue accounting for the largest share of 77% in 2020, mainly due to the rapid increase in the number of new biological sample libraries and the high initial cost of the team. Provide a wide range of equipment to serve different biological sample library processes, such as sample preparation, collection, processing, storage and transportation. Equipment includes cell separators, freezers, defrosting equipment, barcode scanners, and alarm and monitoring systems.

The Laboratory Information Management System (LIMS) department is expected to become a lucrative source of revenue during the forecast period. This is because LIMS plays an important role in COVID-19 biological repositories, testing and research. In April 2020, LabVantage Solutions, Inc. A new COVID-19 LIMS solution was developed. In addition, CloudLIMS also provides its cloud LIMS free of charge to biobanks, research institutions, and laboratories that conduct COVID-19 research or testing around the world.

SERVICE INFORMATION:

The biobank and storage library service sectors dominate the biobank market, accounting for a larger share of revenue in 2020, accounting for 35%. This is due to the higher penetration rate of these services in the market and the greater need for preservation of biological samples to improve accuracy. Research on medicine and specific diseases. The expansion of biobank services from academic research to clinical companies and government initiatives, as well as open and highly connected companies, has promoted the development of this market segment.

The clinical trial and research workflow around COVID-19. Many research institutions and companies are engaged in the development and research of vaccines against the new coronavirus. This is expected to increase the demand for laboratory processing services such as DNA extraction, plasma/serum separation, sample retrieval and sample plates.

INFORMATION ON TYPES OF BIOLOGICAL SAMPLES:

The human tissue part dominates the biobank market, with the highest revenue share in 2020 at 39%. Advanced technology for storing and retrieving storage organizations. It is expected that increased investment in the research and development of specific diseases will drive the demand for tissue samples from lymphoma, myeloma, ovarian leukemia, brain tissue, prostate cancer, breast cancer, and lung colorectal cancer for oncology research. -19 and improve its diagnosis and treatment, it is expected that the human body tissue part will be in high demand in the near future.

Technological advancements, such as using 3D printing for tissue samples/creating miniature 3D printed organs in COVID-19 testing, are expected to drive the growth of this segment. The number of established stem cell biobanks is rapidly increasing worldwide.

The promising applications of stem cells in regenerative medicine, cell therapy, developmental biology, toxicology, and drug development can be attributed to the rapid increase in the number of stem cell banks, which has led to substantial growth in revenue in this segment.

INFORMATION ON THE TYPES OF BIOLOGICAL REPOSITORIES:

Entity/real biological repositories occupy a dominant position in the biological repositories market, with the largest revenue share in 2020 at 81%. These biobanks have a comprehensive network, so their revenue share is relatively high. The rapid progress in the fields of bioinformatics analysis and precision medicine can be attributed to this change in the operating strategy of the biobank. Over the years, a large number of tissue samples from pathology laboratories, clinical trials, and research projects have contributed to most of the tissue bank in 2020.

However, in recent years, virtual biobanks have emerged to solve problems related to the accessibility of biological samples . Tissue Solutions (Scotland) and human-centered testing (Little Port) are examples of organizations whose main operational activities involve collecting and distributing samples as required. The virtual biological library enhances the potential to meet the needs of biological samples and the ability to track and obtain rare samples. In addition, the easy accessibility associated with the virtual biobank contributes to the profitable growth of this market segment.

APPLICATION INSIGHTS:

In 2020, clinical research and drug discovery applications will dominate the biobanking market with a revenue share of 37%. This can be attributed to the increasing demand for biological samples for new drug testing in clinical research. In addition, the number of COVID-19 cases worldwide is increasing exponentially, leading to a growing demand for vaccine development. A number of studies are underway to accelerate research in this field.

For example, the Mayo Clinic has launched an observational study to prospectively collect research biological samples and clinical data from COVID-19 patients to achieve high-quality research, thereby driving the growth of this market segment. On the other hand, the clinical diagnosis part is expected to witness the fastest growth throughout the prophase period. Comparing biological samples obtained from healthy individuals and diseased individuals advances the clinical diagnosis process, especially for cancer. It helps to investigate the patient's response to treatment and to identify new tumors in patients with a history of cancer.

REGIONAL INSIGHTS:

North America will account for the top 33% of revenue share in the global market in 2020 due to continued investment in the collection, creation, and processing of large-scale data sets. For example, in March 2019, the British Biobank generated exome sequence data from 50,000 people, with the goal of advancing disease management, including prevention, diagnosis and treatment. The project aims to collect data on approximately 500,000 people and track their health.

In March 2020, Columbia University and New York Presbyterian Hospital established a COVID-19 biobank for researchers to accelerate their research. In April 2020, Biogen, in cooperation with Partners HealthCare and the Broad Institute of MIT, announced a partnership to establish a COVID-19 biobank. In April 2020, the Quebec COVID-19 biobank began operations in Canada. The biobank was initiated by Genome Québec and Fonds de recherche du Québec. This type of development is expected to boost the source of income in the region.

MAJOR COMPANIES AND MARKET SHARE PROSPECTS:

As the availability of biological samples continues to increase, market participants are expanding their product range to meet the growing demand for biological storage solutions. For example, in February 2020, Hamilton Storage launched a new sample storage tube matched with RackWare shelves at SLAS 2020 International Conference & Expo. Storage and handling of biological samples. Some of the major players in the biobank market include: Thermo Fisher Scientific, Inc.Merck KGaAQIAGENHamilton CompanyAvantorTecan Trading AG.Danaher Corporation Becton, Dickinson and Company (BD) BioCisionTaylor-WhartonCharles River LaboratoriesLonzaSTEMCELL Technologies Inc.Biovault FamilyPromoCellular GmbHPrecision Bank).

MARKET SEGMENTS COVERED BY THE REPORT:

The report forecasts global, regional, and national revenue growth, and analyzes the latest industry trends in each market segment from 2017 to 2028. For the purpose of this research, Kenneth Research has subdivided the global biobank. Market report based on products, services, biological sample types, biobank types, applications, and regions: Product Outlook (Revenue, USD million, 2017- 2028) Biological sample library equipment system control system freezer and refrigerator cryogenic storage system defrosting equipment incubator and centrifuge alarm and monitoring system accessories and other equipment biological sample library consumables laboratory information management system service prospects (revenue, million US dollars, 2022 to 2030).

Biological sample bank and storage laboratory processing qualification/verification cold chain logistics other services os biological sample type perspective (revenue, millions of dollars, 2022 to 2030) human tissue organ stem cells other embryonic stem cells cells other biological samples biological samples Library type perspective (revenue, million dollars, 2022 to 2030) Physical/real biobank tissue biobank biobank based on population diseases-application outlook of virtual biobank based on biobank (DNA/RNA) (revenue, million dollars, 2022 to 2030).

Geography Analysis:

The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:

• North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
• Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
• Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys  & Opportunity Outlook
• Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
• Middle East and Africa  (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook

.